Clinical Consulting is a beneficiary of the project of the Polish Investment and Trade Agency (PAIH) – “Polish Tech Bridges” on the market of Israel.
New draft of the guidance documents applying to clinical trials has been issued in July 2020 by EU.
Wrocław Medical University together with Clinical Consulting has developed the first nationwide clinical trial program in Poland, which gives hope to avoid or reduce severe pulmonary complications during coronavirus infection. 400 patients are planned to be recruited in the study. The study is coordinated by a team of experts from Clinical Consulting and infectious diseases...
Article comes from https://www.prnewswire.com SAN DIEGO, May 14, 2018 /PRNewswire/ — Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Immunopheresis™ therapy, which is based on a proprietary technology that selectively removes...
Polish Ministry of Health, Polish Development Fund and Patient Rights Commissioner have started a campaign to raise patients’ awareness of clinical trials called ‘Patient in Clinical Research’. Clinical trials depend on the patients willingness to participate. When a patient is being informed by a doctor for the first time about clinical trial, there is...
Clinical trial is a situation in which specific group of people take a compound which can become a new medicine. There may also be a situation when a medical device is examined and it can be used to administer a drug or to monitor patients’ vital functions. Clinical trials are a wide subjects on...
Currently, while submitting CTA, Sponsor has to attach signed agreements with all Investigators and sites. We all know how time-consuming it is to negotiate contracts and budget especially with big hospitals where the contacts goes from hands to hands to check it and find the most favorable conditions for either parties. Polish legislator decided...
Regulation 536/2014 regarding the conduct of clinical trials will enter into force in 2019. It will be used directly in all European Union countries. Currently, there is a work under an act which is to regulate the areas that the EU legislator has left you to self-adapt and define for European countries. However, the...
Rare diseases, affect only or as much as 6 – 8% of humanity. They are very rare, but nonetheless exist and people suffer because of them. Orphan drugs – because this is the name of medicinal products used in rare diseases must have an orphan designation by submitting an application for Authorities. The most...
Rare diseases affect only or as much as 6 – 8% of humanity. They are very rare, but they do exist and people suffer from them. In Poland disease is defined as a rare when for 10,000 people up to 5 of them become ill. If you take into account the number of people...
